Perioperative Pembrolizumab Regimen Upholds Survival Benefit in Resectable NSCLC“Key Takeaways: Pembrolizumab plus chemotherapy significantly improved 4-year OS and EFS in resectable early-stage NSCLC compared to chemotherapy alone. The pembrolizumab regimen showed a...
CDC and SAMHSA Leaders Encourage HIV and Viral Hepatitis Testing in Substance Use Disorder Treatment“In a new joint letter, the leaders of the Centers for Disease Control and Prevention (CDC) and the Substance Abuse and Mental Health Services Administration (SAMHSA)...
FDA Grants Taletrectinib Priority Review for Advanced ROS1+ NSCLC“The FDA has granted priority review to a new drug application for taletrectinib, an investigational next-generation ROS1 TKI, for the treatment of patients with advanced ROS1-positive non–small cell...
Hepatocellular Carcinoma Mortality Rates Rising in the US, Driven by Alcohol and Metabolic Liver Diseases“A recent study examined the rising trajectory of hepatocellular carcinoma (HCC) mortality rates in the United States, highlighting stark disparities across age,...
West Virginia Collegiate Recovery Network partners with CHESS Health on hepatitis C digital initiative“The Live(r) Hep C Free program, an initiative of the West Virginia Collegiate Recovery Network (WVCRN) housed within the Marshall University Research Corporation, is...
More News and Updates